Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “infiltrating”

85 pharma patents match "infiltrating" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 85
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 85 pharmaceutical patents matching "infiltrating" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

85 results for “infiltrating” · 30,257 patents in full index Clear search

  1. US 11179419

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  2. US 11168303

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  3. US 11168304

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  4. US 11154574

    Tumor infiltrating lymphocytes and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  5. US 11141438

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  6. US 11123371

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  7. US 11083752

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  8. US 11058728

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  9. US 11052116

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  10. US 11052115

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  11. US 11040070

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  12. US 11026974

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  13. US 11013770

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted

  14. US 11007226

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  15. US 10953047

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  16. US 10953046

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  17. US 10946045

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  18. US 10946044

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  19. US 10933094

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  20. US 10918666

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted

  21. US 10912797

    Tumor infiltrating lymphocytes and methods of therapy

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  22. US 10894063

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  23. US 10695372

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  24. US 10653723

    Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.